Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
US May Prepare Operation to Capture Raul CastroRat Hepatitis E Detected in Hong KongBlackRock Eyes Multi-Billion Dollar Investment in SpaceX IPOTeacher certification exam date announcedNextEra in Talks to Buy Dominion EnergyStrait of Hormuz transit rules changeManchester City Win FA CupWUF13 Kicks Off in Baku TomorrowInnate Pharma Q1 2026 Beats Earnings ExpectationsTrump birthday triggers stock sell-off signalsUS May Prepare Operation to Capture Raul CastroRat Hepatitis E Detected in Hong KongBlackRock Eyes Multi-Billion Dollar Investment in SpaceX IPOTeacher certification exam date announcedNextEra in Talks to Buy Dominion EnergyStrait of Hormuz transit rules changeManchester City Win FA CupWUF13 Kicks Off in Baku TomorrowInnate Pharma Q1 2026 Beats Earnings ExpectationsTrump birthday triggers stock sell-off signals
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU
TRANSCRIPTS

Innate Pharma Q1 2026 Beats Earnings Expectations

Innate Pharma Q1 2026 earnings beat forecasts: EPS surprise 5.82%, revenue up 13.43%, stock jumps 59.56%. Key catalysts include lacutamab, IPH4502, and monalizumab.

Chloe Hall
ByChloe Hall- Senior Editor
|
0
Innate Pharma Q1 2026 Beats Earnings Expectations
Photo: Prepared by Bond.az

Innate Pharma reported better-than-expected earnings for Q1 2026. EPS came in at -0.1522, beating the forecast of -0.1616 by 5.82%. Revenue reached EUR 3.04 million, exceeding the EUR 2.68 million forecast by 13.43%.

Pre-market trading saw a 59.56% surge in stock price from EUR 1.36 to EUR 2.17, reflecting investor confidence in the company's strategic direction and financial performance.

The company is pursuing non-dilutive financing options for the lacutamab Phase III trial. Partnerships with AstraZeneca are progressing well, with monalizumab and IPH5201 showing strong potential.

More News
SAIL reports strong Q4 financial results
Today / 08:50
|
284

SAIL reports strong Q4 financial results

Steel Authority of India reported strong Q4 FY 2025-2026 results with 4% production growth, 5% sales turnover increase, and 48% PBT growth. Stock fell 3.36%.

TRANSCRIPTS →
0
BAT Misses Q1 2026 Forecasts, Stock Dips
Yesterday / 18:03
|
759

BAT Misses Q1 2026 Forecasts, Stock Dips

BAT missed Q1 2026 EPS and revenue forecasts, stock fell 1.71%. Company expects recovery in H2, maintains dividend and buyback.

TRANSCRIPTS →
0
Starwood Property Trust mixed Q1 2026 results
Yesterday / 18:02
|
997

Starwood Property Trust mixed Q1 2026 results

Starwood Property Trust reported mixed Q1 2026 results with EPS below expectations but revenue beating forecasts. The company continues to focus on strategic growth areas.

TRANSCRIPTS →
0
1&1 AG Q1 2026 Revenue Beats Forecasts
Yesterday / 17:50
|
496

1&1 AG Q1 2026 Revenue Beats Forecasts

1&1 AG Q1 2026 revenue of €1.146 billion beats forecasts, net profit up 60.4%. The company continues network expansion and maintains full-year guidance.

TRANSCRIPTS →
0
Salzgitter AG Q1 2026 EPS beats expectations strongly
Yesterday / 17:22
|
462

Salzgitter AG Q1 2026 EPS beats expectations strongly

Salzgitter AG beats Q1 2026 EPS expectations by 131%, reports strong earnings across all segments. Steel production boosts performance.

TRANSCRIPTS →
0
Nissan Q4 2025: Narrower Loss, Stock Up
Yesterday / 17:20
|
559

Nissan Q4 2025: Narrower Loss, Stock Up

Nissan Q4 2025 earnings: EPS beats expectations, revenue slightly misses. Stock rises 2.54%. Progress on Re:Nissan restructuring plan.

TRANSCRIPTS →
0
thyssenkrupp nucera Q2 2026 earnings miss forecasts
Yesterday / 17:10
|
744

thyssenkrupp nucera Q2 2026 earnings miss forecasts

thyssenkrupp nucera Q2 FY2025-2026 results: EPS -0.505 USD, revenue 50 million USD, both below expectations. Order intake at record high. Cost cuts and new product launches planned.

TRANSCRIPTS →
0
XLSMART Q1 2026 revenue up 38%, EPS beats forecast
Yesterday / 17:01
|
382

XLSMART Q1 2026 revenue up 38%, EPS beats forecast

XLSMART Q1 2026 revenue grew 38% to IDR 11.8 trillion, EPS beat forecasts. 5G expansion and integration updates included.

TRANSCRIPTS →
0
NeoVolta Q3 2026 Earnings Miss Forecasts
Yesterday / 17:00
|
438

NeoVolta Q3 2026 Earnings Miss Forecasts

NeoVolta Q3 2026 results: EPS -$0.08, revenue $2M, stock down 10.46%. Updates on Georgia factory and NV Wave platform.

TRANSCRIPTS →
0
Conifex Timber Q1 2026: Loss and Challenges
Yesterday / 16:54
|
887

Conifex Timber Q1 2026: Loss and Challenges

Conifex Timber reported Q1 2026 net loss of CAD 9.4 million. The company targets two-shift operations to restore profitability.

TRANSCRIPTS →
0
Presidio Production Q1 2026 results after merger
Yesterday / 16:34
|
228

Presidio Production Q1 2026 results after merger

Presidio Production Q1 2026 results: merger impact, dividend growth, and operational focus. Read more on Bond.az.

TRANSCRIPTS →
0
Moltiply Group Q1 2026: Strong Growth Amid Challenges
Yesterday / 16:33
|
960

Moltiply Group Q1 2026: Strong Growth Amid Challenges

Moltiply Group Q1 2026 results: revenues up 36.5%, stock down 9.87%. Despite energy challenges, the company maintains growth trajectory with AI and tech investments.

TRANSCRIPTS →
0
...